Unicycive Therapeutics In...

NASDAQ: UNCY · Real-Time Price · USD
4.71
0.08 (1.73%)
At close: Aug 15, 2025, 3:59 PM
4.72
0.32%
After-hours: Aug 15, 2025, 07:57 PM EDT

Unicycive Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
570K -21.52M -4.1M 3.93M -20.96M -7.8M -4.33M -3.84M -14.57M -5.33M -5.56M -3.64M -3.54M -2.75M -5.2M -1.1M -964K
Depreciation & Amortization
135K 134K 123K -113K 284K 82K 79K 78K 45K 42K 40K 40K 39K 1K n/a n/a n/a
Stock-Based Compensation
563K 582K 605K 641K 522K 550K 929K 144K 144K 197K 266K 294K 290K 231K 239K 294K 202K
Other Working Capital
n/a 731K -3.5M 108K 1.07M 694K -1.19M -1.16M 193K -375K -266K 325K 227K 430K -1.72M 45K -99K
Other Non-Cash Items
n/a 12.56M -1.75M -10.88M 11.81M 1.89M -1.4M -282K 10.38M 21K -1.65M 406K 307K -91K 2.77M 441K 271K
Deferred Income Tax
n/a n/a n/a n/a n/a -287K n/a n/a n/a n/a 1.65M -406K n/a n/a n/a n/a n/a
Change in Working Capital
n/a 1.7M -4.13M 108K 1.89M 1.12M 299K -1.6M 91K -1.02M 1.69M 255K 251K 1.21M -1.28M 148K -182K
Operating Cash Flow
-8.9M -6.55M -9.25M -6.32M -6.46M -4.44M -4.42M -5.5M -3.92M -6.08M -3.56M -3.05M -2.96M -1.4M -3.47M -217K -673K
Capital Expenditures
-16K -22K -24K -20K -6K n/a n/a -12K n/a -2K n/a n/a -2K -29K n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-16K -22K -24K -20K -6K n/a n/a -12K n/a -2K n/a n/a -2K -29K n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 174K 701K
Common Stock Repurchased
n/a n/a -13.09B 13.09B n/a -11.66B 10.32B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a -208K n/a -1.09M -208K -867K n/a n/a -192K n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.55M -158K -157K 284K -496K -205K -51K n/a -2.39M -482K n/a n/a n/a 18.72M 21.48M -103K 119K
Financial Cash Flow
2.55M 365K -157K -811K 45.69M -205K -51K n/a 27.8M -471K n/a n/a n/a n/a 21.48M 71K 820K
Net Cash Flow
-6.37M -6.21M -9.43M -7.15M 39.23M -4.64M -4.47M -5.51M 23.88M -6.55M -3.56M -3.05M -2.96M -1.43M 18.01M -146K 147K
Free Cash Flow
-8.92M -6.57M -9.28M -6.34M -6.46M -4.44M -4.42M -5.51M -3.92M -6.09M -3.56M -3.05M -2.96M -1.43M -3.47M -217K -673K